Icon Plc (ICLR) Growth Rates Comparisons to Medical Laboratories Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Icon Plc  (NASDAQ: ICLR)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Icon Plc Growth Comparisons

Select each growth Category to receive further Information





ICLR Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 1.2 % 11.11 % 8.07 % 9.17 %
Q / Q Revenue Growth (Q2 MRQ) 1.45 % 1.31 % 1.81 % 4.22 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 2.88 % 6.47 % 7.04 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 0.29 % 1.92 % 3.51 % 2.08 %
Revenue 5 Year Average Growth 24.15 % 13.12 % 8.65 % 10.59 %


ICLR's Growth Comparisons in II. Quarter 2026




Icon Plc's Revenue slowed to the 1.2% year on year, improvement in the second quarter 2026 to 2.06 billions, underperforming the 11.11% rise in the Medical Laboratories industry and 8.07% Revenue growth in the Healthcare sector. Comparing the second quarter, sales Icon Plc was trailing overall market not just Medical Laboratories industry.

Comparing the company's Revenue to the first quarter results, sales were higher by 1.45% . On the yearly basis, average annual sales growth for Icon Plc is 24.15%, while S & P 500's including only Businesses with the second quarter 2026 earnings, average annual sales growth is 10.59% over the past five years.

ICLR Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Top client
-
-
Clients 2-5
-
-
Clients 6-10
-
-
Clients 11-25
-
-
Other
-
-
Ireland
-
-
Rest of Europe
-
-
U S
-
-
Rest of World
-
-
Total
-
-


Growth Rates of ICLR's Income in the second quarter 2026


ICLR Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) -40.32 % 3.74 % 27.58 % 29.95 %
Sequential Operating Income Change (Q2 MRQ) -20.67 % -7.28 % -17.34 % 4.5 %
Y / Y Operating Income Growth (Q2 TTM) -71.4 % 68.48 % 37.03 % 14.37 %
Sequential Operating Income Growth (Q2 TTM) -14.91 % 15.03 % 9.74 % 6.96 %
Operating Income 5 Year Avg. Change 2.5 % 6.34 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - -74.8 % - 21.83 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) -30.71 % -27.4 % - 11.13 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) -75.51 % -39.26 % -25.13 % 16.46 %
Sequential Income from Cont. Ops. Change (Q2 TTM) 21.73 % -24.71 % -6.43 % 6.05 %
Income from Cont. Ops. 5 Year Avg. Change -7.19 % 5.07 % 0.17 % -28.52 %

ICLR Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) -60.33 % 46.12 % 16.75 % 21.56 %
Q / Q Net Income Growth (Q2 MRQ) -30.71 % -27.26 % -34.6 % 11.12 %
Y / Y Net Income Change (Q2 TTM) -91.24 % 8.93 % 32.74 % 16.59 %
Sequential Net Income Change (Q2 TTM) -61.35 % 58.22 % 7.31 % 6.03 %
Net Income 5 Year Avg. Growth -7.19 % 5.34 % 9.21 % 22.96 %

ICLR's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) -63.4 % -75.82 % - 21.83 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) -31.39 % -27.3 % - 11.13 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) -60.39 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) -27.73 % - - -99.7 %
EPS from Cont. Ops. 5 Year Avg. Growth -14.19 % -8.23 % 0.17 % -28.52 %



ICLR EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) -63.26 % 40.22 % 16.75 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) -30.88 % -27.16 % -34.6 % 11.12 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - -99.97 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) -27.72 % - - -99.87 %
EPS Net 5 Year Avg. Change -14.18 % 5.34 % 9.21 % 22.96 %



As Icon Plc's income per share faded by -63.26% year on year in the second quarter, Medical Laboratories industry grew by 40.22%, Icon Plc's second quarter performance was trailing Medical Laboratories, and underperformed the 16.75% EPS improvement in the Healthcare sector. Comparing second quarter, income per share Icon Plc was trailing overall market not just Medical Laboratories industry.

Bottom-line fell by -30.88% from the first quarter results. Comparing the annual growth, income per share of -14.18% on average in last five years, to the S & P 500's, including only Businesses with the second quarter 2026 earnings, average yearly income per share growth is 22.96%. Icon Plc grew less than the market.

ICLR Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 103.63 % -25.07 % -10.43 % 2 %
Sequential Free Cash Flow Change (Q2 MRQ) 75.32 % -8.23 % -28.82 % 22.32 %
Y / Y Free Cash Flow Change (Q2 TTM) -59.79 % 18.54 % 11.09 % 11.81 %
Sequential Free Cash Flow Change (Q2 TTM) 17.34 % -2.51 % 1.93 % 2.41 %
Free Cash Flow 5 Year Avg. Change 14.73 % 10.39 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - -90.24 % 1035.72 %
Sequential Net Cash Flow Change (Q2 MRQ) - 28.43 % -99.01 % -
Y / Y Net Cash Flow Change (Q2 TTM) - 110.21 % -23.28 % -
Sequential Net Cash Flow Change (Q2 TTM) - 182.1 % -25.11 % -
Net Cash Flow 5 Year Avg. Change -19.45 % -9.51 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 46.75 % 24.59 % 9.45 % 23.41 %
Sequential Capital Expenditures Change (Q2 MRQ) 37.86 % 41.29 % 18.78 % 18.97 %
Y / Y Capital Expenditures Change (Q2 TTM) 9.53 % 9.96 % 10.57 % 23.88 %
Sequential Capital Expenditures Change (Q2 TTM) 5.78 % 8.68 % 6.56 % 7.02 %
Capital Expenditures 5 Year Avg. Change 27.82 % 8.61 % 9.12 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.